-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Scinai Immunotherapeutics Ltd. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from 2021 to 2023.
- Scinai Immunotherapeutics Ltd. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $138K, a 2.99% increase year-over-year.
- Scinai Immunotherapeutics Ltd. annual Depreciation, Depletion and Amortization for 2023 was $514K, a 8.54% decline from 2022.
- Scinai Immunotherapeutics Ltd. annual Depreciation, Depletion and Amortization for 2022 was $562K, a 19.3% increase from 2021.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)